Defendant Name: Stryker Corporation

Defendant Type: Public Company
SIC Code: 3841
CUSIP: 86366710

Initial Case Details

Legal Case Name In the Matter of Stryker Corporation
First Document Date 28-Sep-2018
Initial Filing Format Administrative Action
File Number 3-18853
Allegation Type Foreign Corrupt Practices Act
AAER 3990

Violations Alleged

Exchange Act
Sec 13(b)(2)(A)
Sec 13(b)(2)(B)

Resolutions

First Resolution Date 28-Sep-2018
Headline Total Penalty and Disgorgement $7,800,000

Related Documents:

34-84308 28-Sep-2018 Administrative Proceeding
Order Instituting Cease-and-Desist Proceedings Pursuant to Section 21C of the Securities Exchange Act of 1934, Making Findings, and Imposing Remedial Sanctions and a Cease-and-Desist Order
The Commission stated: "This matter concerns violations of the books and records and internal accounting controls provisions of the Exchange Act by Stryker, a global leader in the medical technology industry, related to its operations in India, China, and Kuwait."
2018-222 28-Sep-2018 Press Release--Administrative Proceeding
SEC Charges Stryker A Second Time for FCPA Violations
The Commission stated: "The Securities and Exchange Commission today charged Stryker Corp. with violating the books and records and internal accounting controls provisions of the Foreign Corrupt Practices Act (FCPA), the second time the SEC has brought an FCPA action against the Michigan-based medical device company."